GlassScriptPhysician profile
Donna Perkins
NPI 1053369553
$7,424.19
in general payments reported to CMS, 2019-2025
43 companies · $802 in 2025
The $802 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,887 · 2022: $1,807 · 2023: $1,550 · 2024: $1,378 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,730.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $739.21 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $653.35 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $556.78 | 2021-2025 | Xifaxan, Relistor |
| Novartis Pharmaceuticals Corporation | $407.02 | 2021-2024 | |
| Astellas Pharma US INC | $406.65 | 2021-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $344.58 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.08 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $333.60 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Phathom Pharmaceuticals, INC. | $323.60 | 2023-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $278.12 | 2021-2022 | |
| Pfizer INC. | $263.93 | 2021-2023 | |
| Exact Sciences Corporation | $233.39 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $227.09 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $220.89 | 2021-2023 | Verquvo, Lagevrio, Steglatro |
| Scilex Pharmaceuticals INC. | $206.07 | 2021-2024 | Ztlido |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.